|
|
 |
|
Viewing report
|
|
|
|
India Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Jan 2012, Pages: 87
Business Monitor International's India Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on India's pharmaceuticals and healthcare industry.
BMI View:
India's pharmaceutical market will increasingly attract foreign drugmakers. The government has made a clear statement that it values the contribution of multinationals to the overall economy. BMI believes firms should engage with local producers, patient groups, regulators and other stakeholders. The key operational risk is India's parochial notion that uncontrolled foreign intervention will deny cheap drugs to the population.
REASONS TO BUY
- Benchmark BMI's Independent 5-year Pharmaceutical and Healthcare Industry Forecasts on India to test other views - a key input for successful budgeting and strategic business planning in the India pharmaceutical and healthcare market.
- Target Business Opportunities & Risks in the India Pharmaceutical and Healthcare Sector through BMI's reviews - and major deals, projects and investments in India.
- Exploit The Latest Competitive India Pharmaceutical and Healthcare Intelligence & company SWOTS on your competitors and peers through company rankings by sales, market share and ownership structure – includes multi-national and national companies in India.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
